313 related articles for article (PubMed ID: 17588519)
1. Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome.
Chen X; Barton LF; Chi Y; Clurman BE; Roberts JM
Mol Cell; 2007 Jun; 26(6):843-52. PubMed ID: 17588519
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway.
Li X; Amazit L; Long W; Lonard DM; Monaco JJ; O'Malley BW
Mol Cell; 2007 Jun; 26(6):831-42. PubMed ID: 17588518
[TBL] [Abstract][Full Text] [Related]
3. Oxidative challenge enhances REGγ-proteasome-dependent protein degradation.
Zhang Y; Liu S; Zuo Q; Wu L; Ji L; Zhai W; Xiao J; Chen J; Li X
Free Radic Biol Med; 2015 May; 82():42-9. PubMed ID: 25656993
[TBL] [Abstract][Full Text] [Related]
4. REGgamma proteasome mediates degradation of the ubiquitin ligase Smurf1.
Nie J; Wu M; Wang J; Xing G; He F; Zhang L
FEBS Lett; 2010 Jul; 584(14):3021-7. PubMed ID: 20580715
[TBL] [Abstract][Full Text] [Related]
5. Site-specific acetylation of the proteasome activator REGγ directs its heptameric structure and functions.
Liu J; Wang Y; Li L; Zhou L; Wei H; Zhou Q; Liu J; Wang W; Ji L; Shan P; Wang Y; Yang Y; Jung SY; Zhang P; Wang C; Long W; Zhang B; Li X
J Biol Chem; 2013 Jun; 288(23):16567-16578. PubMed ID: 23612972
[TBL] [Abstract][Full Text] [Related]
6. REGgamma, a proteasome activator and beyond?
Mao I; Liu J; Li X; Luo H
Cell Mol Life Sci; 2008 Dec; 65(24):3971-80. PubMed ID: 18679578
[TBL] [Abstract][Full Text] [Related]
7. The REGγ inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells.
Gao X; Wang Q; Wang Y; Liu J; Liu S; Liu J; Zhou X; Zhou L; Chen H; Pan L; Chen J; Wang D; Zhang Q; Shen S; Xiao Y; Wu Z; Cheng Y; Chen G; Kubra S; Qin J; Huang L; Zhang P; Wang C; Moses RE; Lonard DM; Malley BWO; Fares F; Zhang B; Li X; Li L; Xiao J
Nat Commun; 2020 Aug; 11(1):3904. PubMed ID: 32764536
[TBL] [Abstract][Full Text] [Related]
8. Regulation of REGγ cellular distribution and function by SUMO modification.
Wu Y; Wang L; Zhou P; Wang G; Zeng Y; Wang Y; Liu J; Zhang B; Liu S; Luo H; Li X
Cell Res; 2011 May; 21(5):807-16. PubMed ID: 21445096
[TBL] [Abstract][Full Text] [Related]
9. The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome.
Li X; Lonard DM; Jung SY; Malovannaya A; Feng Q; Qin J; Tsai SY; Tsai MJ; O'Malley BW
Cell; 2006 Jan; 124(2):381-92. PubMed ID: 16439211
[TBL] [Abstract][Full Text] [Related]
10. The REGγ proteasome regulates hepatic lipid metabolism through inhibition of autophagy.
Dong S; Jia C; Zhang S; Fan G; Li Y; Shan P; Sun L; Xiao W; Li L; Zheng Y; Liu J; Wei H; Hu C; Zhang W; Chin YE; Zhai Q; Li Q; Liu J; Jia F; Mo Q; Edwards DP; Huang S; Chan L; O'Malley BW; Li X; Wang C
Cell Metab; 2013 Sep; 18(3):380-91. PubMed ID: 24011073
[TBL] [Abstract][Full Text] [Related]
11. Proteasomes reactivator REG gamma enchances oncogenicity of MDA-MB-231 cell line via promoting cell proliferation and inhibiting apoptosis.
Tian M; Xiaoyi W; Xiaotao L; Guosheng R
Cell Mol Biol (Noisy-le-grand); 2009 Jun; 55 Suppl():OL1121-31. PubMed ID: 19656465
[TBL] [Abstract][Full Text] [Related]
12. S100A11 is involved in the regulation of the stability of cell cycle regulator p21(CIP1/WAF1) in human keratinocyte HaCaT cells.
Foertsch F; Teichmann N; Kob R; Hentschel J; Laubscher U; Melle C
FEBS J; 2013 Aug; 280(16):3840-53. PubMed ID: 23745637
[TBL] [Abstract][Full Text] [Related]
13. Regulation of energy homeostasis by the ubiquitin-independent REGγ proteasome.
Sun L; Fan G; Shan P; Qiu X; Dong S; Liao L; Yu C; Wang T; Gu X; Li Q; Song X; Cao L; Li X; Cui Y; Zhang S; Wang C
Nat Commun; 2016 Aug; 7():12497. PubMed ID: 27511885
[TBL] [Abstract][Full Text] [Related]
14. Regulation of c-Myc protein stability by proteasome activator REGγ.
Li S; Jiang C; Pan J; Wang X; Jin J; Zhao L; Pan W; Liao G; Cai X; Li X; Xiao J; Jiang J; Wang P
Cell Death Differ; 2015 Jun; 22(6):1000-11. PubMed ID: 25412630
[TBL] [Abstract][Full Text] [Related]
15. ARF regulates the stability of p16 protein via REGγ-dependent proteasome degradation.
Kobayashi T; Wang J; Al-Ahmadie H; Abate-Shen C
Mol Cancer Res; 2013 Aug; 11(8):828-33. PubMed ID: 23817020
[TBL] [Abstract][Full Text] [Related]
16. SCFFbl12 Increases p21Waf1/Cip1 Expression Level through Atypical Ubiquitin Chain Synthesis.
Tsuruta F; Takebe A; Haratake K; Kanemori Y; Kim J; Endo T; Kigoshi Y; Fukuda T; Miyahara H; Ebina M; Baba T; Chiba T
Mol Cell Biol; 2016 Aug; 36(16):2182-94. PubMed ID: 27215384
[TBL] [Abstract][Full Text] [Related]
17. REGγ is a strong candidate for the regulation of cell cycle, proliferation and the invasion by poorly differentiated thyroid carcinoma cells.
Zhang M; Gan L; Ren GS
Braz J Med Biol Res; 2012 May; 45(5):459-65. PubMed ID: 22415115
[TBL] [Abstract][Full Text] [Related]
18. REGγ regulates ERα degradation via ubiquitin-proteasome pathway in breast cancer.
Chai F; Liang Y; Bi J; Chen L; Zhang F; Cui Y; Jiang J
Biochem Biophys Res Commun; 2015 Jan; 456(1):534-40. PubMed ID: 25490392
[TBL] [Abstract][Full Text] [Related]
19. Expression of proteasome activator REGγ in human laryngeal carcinoma and associations with tumor suppressor proteins.
Li LP; Cheng WB; Li H; Li W; Yang H; Wen DH; Tang YD
Asian Pac J Cancer Prev; 2012; 13(6):2699-703. PubMed ID: 22938444
[TBL] [Abstract][Full Text] [Related]
20. PKA turnover by the REGγ-proteasome modulates FoxO1 cellular activity and VEGF-induced angiogenesis.
Liu S; Lai L; Zuo Q; Dai F; Wu L; Wang Y; Zhou Q; Liu J; Liu J; Li L; Lin Q; Creighton CJ; Costello MG; Huang S; Jia C; Liao L; Luo H; Fu J; Liu M; Yi Z; Xiao J; Li X
J Mol Cell Cardiol; 2014 Jul; 72():28-38. PubMed ID: 24560667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
